AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities

Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal Cancer

Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered

Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome

Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM

Endpoints NewsFDA warns telehealth companies over compounded GLP-1s

BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA

Endpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says

Endpoints NewsHackers claim they stole Novo Nordisk AI models, manufacturing recipes

Endpoints NewsIn second reversal, FDA gives uniQure a green light to seek accelerated approval

BioPharma DiveJazz zeroes in on next-gen T cell engagers with AbCellera deal

Clinical OMICsVibrating Pill Predicts Anorexia Relapse

BioWorldFlexibility restored? Uniqure plans for BLA filing in Huntington’s